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Protein kinase C (PKC) from a human mcgakaryoblastic leukemic ell line (MEG-01) was resolved into two fractions by hydroxyapatitc column 
chromatography, which arc indistinguishable. from the brain type II (j?I//?II) and type III (u) subspecies, by biochemical nd immunoblot analysis. 
In the presence of both phosphatidylserine and diacylglycerol, several free unsaturated fatty acids (FFA’s), such as arachidonic, oleic, linoleic and 
linolenic acids, further enhanced the enzyme activation, and allowed the enzyme to exhibit almost full activity at nearly basal evels of Cat+ conccn- 
tration. The concentration of unsaturated FFA’s giving rise to the maximum enzyme activation was around 2 x lO-s M. Palmitic and stearic 
acids were inactive. The result implies that, in addition to diacylglycerol, the receptor-mediated r lease of unsaturated FFA’s from membrane phos- 
pholipids may also take part in the activation of PKC. 
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1. INTRODUCTION 
The signal-dependent hydrolysis of inositol phospho- 
lipids, particularly phosphatidylinositol bisphosphate, 
catalyzed by phospholipase C is generally accepted to 
be a key event for .initiating cellular responses [ 1,2]. Re- 
cent studies suggest hat the receptcr-mediated hydro- 
lysis of phosphatidylcholine (PC) also plays a role in 
cellular responses, including cell proliferation and dif- 
ferentiation [3]. In fact, both phospholipase AZ and 
phospholipase D appear to be involved in the PC 
hydrolysis, which is often observed at a relatively later 
phase of cellular responses [3-51. It is becoming plausi- 
ble that sustained activation of protein kinase C (PKC) 
is necessary, especially for long-term responses; for in- 
stance, T-lymphocyte activation [6] and HL-60 cell dif- 
ferentiation [7-g]. Since the activation of PKC due to 
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the inositol phospholipid hydrolysis is normally tran- 
sient, DAG [3] and unsaturated free fatty acids (FFA’s) 
[10-U] which may be derived from PC hydrolysis have 
been postulated as secoud messengers for PKC activa- 
tion. 
In a human megakaryocytic cell line, MEG-01, the 
P-subspecies of PKC is shown to be a predominant 
form by immunoblot analysis [161. A potential role of 
PKC in the differentiation of megakaryocytes has been 
suggested by Ogura et al. [17], who have shown that a 
tumor-promoting phorbol ester stimulates MEG-01 
cells to differentiate into more mature megakaryocytes, 
in several morphological and biochemical criteria. In 
human platelets, on the other hand, there are two PKC 
subspecies, one of which is indistinguishable from the 
a-subspecies of the brain PKC, whereas the other is 
kinetically different from, but resembles, the & 
subspecies [18]. To explore the potential role of PKC 
activation during differentiation of MEG-01 cells to 
undergo terminal maturation, the present studies were 
made to identify the PKC subspecies in this blastic cell 
line, and show that the enzyme can be activated by 
synergistic action of DAG and unsaturated FFA’s. 
2. MATERIALS AND METHODS 
2.1, Materials arrd chemicals 
[-,_+]ATP was a product of New England Nuclear. Calf thYmUS 
l-l 1 histone was prepared as described [ 191 I Phospholipids, BAG and 
aii FFA’s were purchased from Serdary Kescarcll Laboratories. 
MEG-01 cells were kindly donated by Dr. Saito, Nagoya University, 
Japan. 
Volume 288, number I,2 FEES ZETTEii.S August 1991 
2.2. Cell culture 
The human megakaryoblastic leukemic cell line, designated MEG- 
01, has been established by Ogura et al. [20]. The cells were grown in 
RPM1 1640 medium (Flow Laboratories) supplemented with 10% 
fetal bovine serum (Whittaker), penicillin G (100 U/ml) and strep- 
tomycin (100 pg/ml) at 37°C in a humidified atmosphere of 5% CO2 
and 95Yo air. The cells, cultured for 24 h on dishes at l-2 x 106/ml 
in a to!?1 of 100 ml medium, were used. The basal PKC activity did 
not vXy with ccl1 density over the range described. 
2.3. Preparation of PKC subspecies 
All procedures were carried out at 4’Y. MEG-01 cells (l-2 x IO8 
cells) were suspended in 4 ml of 20 mM Tris-HCI (pH 7.5) containing 
1 mM EGTA, 1 mM EDTA, 0.25 sucrose, 1 mM phenylmethylsul- 
fonyl fluoride and 0.4 mM leupeptin. The cells were lysed by sonica- 
tion for 6 x 10 s. and the homogenate was centrifuged for 60 min at 
100 O!JO x g. The supernatant was applied to a DEAE-cellulose coi- 
umn (column volume 4 ml, Whatman) which was equilibrated with 20 
mM Tris-HCI (pH 7.5) containing 0.5 mM EGTA, 0.5 mM EDTA 
and 10 mM 2-mcrcaptoethanol (buffer A). After washing the column 
with 20 ml buffer A, PKC was eluted with 10 ml buffer A containing 
0.S M NaCI. The sample was applied to a packed hydroxyapatite col- 
umn (0.78 x 15 cm, Koken Ltd, Tokyo), connected to an FPLC 
system (Pharmacia) that was equilibrated with 20 mM potassium 
phosphate (pH 7.5) containing 0.5 mM EGTA, 0.5 mM EDTA, 10 
mM I-mercaptoethanol and 10% (v/v) glycerol (buffer 8). The col- 
umn was washed with 24 ml buffer B, and PKC was cluted by applica- 
tion of a linear concentration gradient of potassium phosphate (20 
mM to 200 mM) in 84 ml buffer B at a flow rate of 0.4 ml/min. Frac- 
tions of 1 ml each were collected, dialyzed against buffer A containing 
10% (v/v,\ glycerol. and stored at -8O’C. The rat brain PKC 
subspecies were prepared as described 1121. 
2.4. Assay of PKC 
The enzyme activity was assayed by measuring the incorporation of 
“Pi into calf thymus. H 1 histone from (y-“P]ATP. The reaction mix- 
ture (final volume, 0.25 ml) contained 20 mM Tris-HCI (pH 7.5), IO 
mM MgClz, 10 PM [y-“P]ATP (0.5-I x 10’ cpm/pmol), 50 pg HI 
histone and other chemicals including CaCl2 (10 - ‘ M), PS (8 ccl/ml), 
DAG (0.8 pg/ml), FFA’s (20 PM) and enzyme fraction unless other- 
wise indicated. PS and DAG were mixed first in chloroform and dried 
under nitrogen. The residue was then resuspended in 20 mM Tris-HCI 
(PI-1 7.5) by vortexing and sonication on ice for 3 x I min under 
nitrogen. FFA normally dissolved in ethanol was diluted with 20 mM 
Tris-MCI (pH 7.5), sonicated as above, and added to the reaction mix- 
ture directly. The reaction was started by the addition of enzyme. 
After incubation for 3 min at 30% the acid-precipitable materials 
were collected on a nitroccllulose filter. The radioactivity was quan- 
titated using a scintillation spectrometer by Cerenkov counting as 
described [ 121. One unit of PKC was defined as the amount of enzyme 
that incorporates 1 nmol of “Pi from [y-3ZP]ATP into HI histone per 
min under the conditions described above. 
2.5. Immunoblot analysis 
lmmunoblot analysis was carried out as described [21]. The PKC 
fractions of hydroxyapatite column chromatography were subjected 
to SDS-polyacrylamide gel elcctrophoresis, and transferred to a 
nitrocellulose filter. The filter was reacted with the PKC subspecies- 
specific antibodies, and stained by the avidin-biotin peroxidasc com- 
plcx method. The antibodies wt. 2 raised against the synthetic 
oligopeptides which are parts of the deduced amino acid sequence of 
PKC (211. The antibodies, CKpVl /3-a and CKpV5 ~-8, reacted 
specifically with 13 (flI/flIl)- and a-PKC, respectively. 
3. RESULTS 
3.1. Isolation of PKC subspecies 
PKC from MEG-01 cells was resolved into two 
distinct fractions (peaks a and b) upon hydroxyapatite 
column chromatography (Fig. 1A). The peak a and b 
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Fig. 1. Chromatographic profiles of PKC subspecies of MEG-01 cells 
and rat brain. The sample from the DEAE-cellulose column was sub- 
jected to hydroxyapatite column chromatography and assayed as 
described in section 2. A. PKC of MEG-O! cc&; 3. PKC of tbe rat 
brain. (e-e), in the presence of 0.2 mM CaClz, 8 &ml PS and 0.8 
ag/ml DAG; (w), in the presence of 2.5 mM EGTA instead of 
CaCl2, PS and DAG. 
enzymes were eluted at the positions corresponding to 
the rat brain type II (0) and type III (CY) PKC, respec- 
tively (Fig. 1 B). Both enzymes howed an approximate 
molecular weight of 80 kDa as estimated by SDS- 
polyacrylamide gel electrophoresis. Immunoblot 
analysis indicated that the peak a enzyme (fraction 
number 3 I-37) reacted with the antibody specific to the 
brain @-PKC, and the peak b enzyme (fraction number 
52-61) reacted with the antibody specific to the brain (Y- 
PKC (Fig. 2). Both enzymes did not react with the an- 
tibodies specific to the PKC subspecies having the 6-, E- 
or {-sequence. 
3.2. Synergistic action of DAG and arachidonic acid 
The peak a and b enzymes were activated by DAG in 
the presence of PS at the micromolar range of CaZf , 
and PS alone activated both enzymes only at higher 
concentrations of Ca”+, around 10e4 M (Fig. 3A and 
B). DAG alone was inactive. The activity of both en- 
zymes was greatly enhanced further by arachidonic acid 
in addition to DAG and PS (Fig. 3C and D). The 
stimulatory actions of DAG and arachidonic acid were 
synergistic, and more predominant at lower Ca’+ con- 
centrations. Both peak a and b enzymes exhibited 
almost full activity at nearly basal evels of Ca*+ (Fig. 
3C and D). In the absence of PS, arachidonic acid and 
DAG slightly activated both enzymes. The arachidonic 
acid alone showed some stimulatory effect on tile peak 
b enzyme, The concentration of arachidonic acid giving 
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Fig. 2. lmmunoblot analysis of PKC fractions of MEG-01 cells. The PKC fractions of hydroxyapatite column chromatography were subjected 
to immunoblot analysis as described in section 2. A. Immunoblot analysis with polyclonal antibody, CKpVl &a, which recognized specifically 
the B-subspecies. B. lmmunoblot analysis with polyclonal antibody, CKpV5 a-a, which recognized specifically the cu-subspecies. Lane 1, 2, 3, 4, 
5; fraction number 28,3 1,34,37.43, respectively (peak a). Lane 6,7; fraction number 52-56,57-61, respectively (peak b). Lane 8.9, 10; authentic 
samples of (Y-, fl- and yPKC from the rat brain, respectively. 
CaCl2 (M) 
Fig. 3. Activation of PKC fractions by arachidonic acid in the 
presence of PS, DAG and various concentrations of Ca2 l . Each PKC 
fraction from MEG-01 cells (approximately 0.015 Unit) was assayed 
with H1 histone as substrate under the conditions described in section 
2, cxccpt that various conccntralions of Cat% were added in the 
absence (A, B) or presence (C, D) of 20/rM arachidonic acid. Where 
indicated with arrows, 2.5 mM EGTA was added instead of Cat%. A 
and C, peak a; Band D, peak b. (o--e), in the prescncc of PS and 
DAG; (O--.0), in the prcscncc of DAG; (m---m), in the prcacncc of 
0 20 40 60 80 100 0 20 40 60 80 100 
Arachidonic Acid (pM) 
Fig. 4. Activation of PKC fractions by arachidonic acid at vorious 
concentrations in the presence of PS, DAG and Cal* I Each PKC 
fraction from MF.G-OI cells (approximately 0.015 Unil) was assayed 
wi!h HI histonc as substrate under the conditions dcscrlbcd in section 
2, cxccpt that various concentrations of arachidonic acid wcrc added 
as Indicated. A, peak a; B, peak b. (o-+), in the prcscnce of PS 
and DAG; (O---O), in the prcscncc of DAG: (m---m), in the 
PS; (X--- x), in the abscncc of PS and DAG. prcscncc of PS; (x--- x), in the absence of PS and DAG. 
rise the maximum effect in the presence of PS and DAG 
was 2 x lo-’ M (Fig. 4). Higher concentrations of 
arachidonic acid were rather inhibitory. 
3.3. Specificity of fatty acid 
The synergistic action of DAG and arachidonic acid 
39 
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Fig. 5. Activation of PKC fractions by various FFA’s in the presence 
of PS, DAG and Ca’ + . Each PKC fraction from MEG-01 cells (ap- 
proximately 0.015 Unit) was assayed with HI histone as substrate 
under the conditions described in section 2, except that various fatty 
acids (20 aM each) were added as indicated. A, peak a; B, peak b. 
on the enzyme activation described above was observed 
also for many other unsaturated FFA’s, such as 
linoleic, linolenic and oleic acids (Fig. 5). Palmitic and 
stearic acids were inactive. The stimulatory effect of 
DAG and unsaturated FFA was more remarkable for 
the peak b than for the peak a enzyme. 
4. DISCUSSWN 
MEG-01 cells contain two PKC enzymes, correspon- 
ding the brain CY- and &subspecies. Kinetic analysis with 
Hl histone as phosphate acceptor eveals that both en- 
zymes respond well to PS and DAG, and are sensitive to 
Ca*+. On the other hand, human platelets do not ap- 
pear to express the P-subspecies but contain, in addition 
to the ar-subspecies, a structurally unidentified PKC 
subspecies which does not depend on Ca2+ but 
responds only partially to PS and DAG [18j. Pre- 
sumably, these PKC subspecies play distinctly different 
roles during the differentiation of megakaryoblasts o
platelets. 
Both PKC enzymes found in MEG-01 cells were ac- 
tivated significantly by the simultaneous addition of 
DAG and unsaturated FFA’s in the presence of PS. Un- 
saturated FFA’s together with DAG increased an ap- 
parent affinity of the PKC for Ca'+ , and activated the 
enzyme almost fully at the basal level of Ca2 + concen- 
trations. Although Ihe physiological significance of this 
synergistic action of unsaturated FFA’s and DAG re- 
mains to be explored further, it is possible that the PKC 
once activated by the hydrolysis of inositol phospholi- 
40 
pids remains active even after the Ca2+ concentration 
returns to the basal evel, when DAG and unsaturated 
FFA’s are both available. Perhaps, several phospho- 
lipase activated in a signal-dependent manner may take 
part in cell growth and differentiation that apparently 
require sustained activation of PKC. 
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